jaime ponce md, facs, fasmbs director of bariatric surgery hamilton medical center dalton georgia...
TRANSCRIPT
![Page 1: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/1.jpg)
Jaime Ponce MD, FACS, FASMBSDirector of Bariatric SurgeryHamilton Medical CenterDalton Georgia USA
LAGB Weight Loss and LAGB Weight Loss and DiabetesDiabetes
2010 Minimally Invasive Surgery SymposiumSan Diego CAFebruary 25, 2010
![Page 2: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/2.jpg)
DisclosuresDisclosures
• Allergan:– Consultant, Proctor, Research, Speaker, use the
Lap-Band® in my private practice
• Ethicon Endo-Surgery:– Consultant, Proctor, Speaker, use the Realize™
Band in my private practice
![Page 3: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/3.jpg)
Effects in Diabetes and Metabolic Effects in Diabetes and Metabolic SyndromeSyndrome
• Weight loss has a positive effect• LAGB programs with good understanding and
intense follow-up, have documented significant improvement in DM and Metabolic Syndrome
![Page 4: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/4.jpg)
Change in Diabetes Status 1 Year After LAP-BAND System Surgery
Remission = Normal fasting glucose, HbA1c,* insulin, C-peptide, and no diabetes medication 32 patients (64%)
Improved = Significant improvement in control and reduction of diabetes medication 13 patients (26%)
No change = No change in diabetic control or therapy 5 patients (10%)
*At 1 year only 3 (6%) had HbA1c >7%.
Dixon et al. Dixon et al. Diabetes CareDiabetes Care. 2002;25:358-363. 2002;25:358-363
![Page 5: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/5.jpg)
Predictors of Remission
• Weight loss (% EWL)
– pr2 = 0.37, P<0.001
• Time with a diagnosis of diabetes
– pr2 = 0.24, P=0.003
– Combined pr2 = 0.44, P<0.001
Dixon et al. Dixon et al. Diabetes CareDiabetes Care. 2002;25:358-363.. 2002;25:358-363.
![Page 6: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/6.jpg)
Change with Weight Loss: HOMA %S
-40
-30
-20
-10
0
10
20
30
40
50
% C
hang
e
Change in % Insulin sensitivity
Normal fasting glucose Impaired fasting glucose Type 2 diabetes
Diabetic Medicine 2003;20:127-34.
![Page 7: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/7.jpg)
Change with Weight Loss: HOMA %S & %B
-40
-30
-20
-10
0
10
20
30
40
50
% C
hang
e
Change in % Insulin sensitivity Change in % Beta-cell function
Normal fasting glucose Impaired fasting glucose Type 2 diabetes
![Page 8: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/8.jpg)
Change with Weight Loss: HOMA %S & %B, HbA1c
-40
-30
-20
-10
0
10
20
30
40
50
% C
hang
e
Change in % Insulin sensitivity Change in % Beta-cell function Precentage change in HbA1c
Normal fasting glucose Impaired fasting glucose Type 2 diabetes
![Page 9: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/9.jpg)
Change with Weight Loss: HOMA %S & %B, HbA1c
-40
-30
-20
-10
0
10
20
30
40
50
% C
hang
e
Change in % Insulin sensitivity Change in % Beta-cell function Precentage change in HbA1c
Normal fasting glucose Impaired fasting glucose Type 2 diabetes
Time with diabetes
R=-0.36, p=0.02
![Page 10: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/10.jpg)
Fasting plasma glucose: Median +/- IQ range
3
4
5
6
7
8
9
10
11
12
Pre-operative 1-year 2-year 3-year 4 or more years
Diabetes
Impaired Fasting glucose
Normal Fasting glucose
* and ** are significantly different p<0.001 when grouped together
**
****
![Page 11: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/11.jpg)
HTN and T2DM After LAGB in Glucose Intolerance Subjects
• Pontiroli, et al Univ of Milano, Italy: Diabetes Care Nov 2005;28:2703-9– 4-year case-controlled study in impaired Glucose-Tolerance pts: LAGB
vs conventional diet in prevention (56 vs 29 pts) and remission (17 vs 20 pts) of DM
– 73 LAGB pts vs 49 pts refused LAGB but agreed f/u with diet– BMI change: 45.9 to 37.7 vs 45.2 to 46.5
– Progression to T2DM: 0% vs 17.2%– Remission T2DM: 45% vs 4%
– Progression to HTN: 1.4% vs 25.6%– Remission HTN: 20.5% vs 2.3%
![Page 12: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/12.jpg)
LAGB and Diabetes
• Dolan and Fielding. Obes Surg, 2004– 88 patients, BMI 45, Type II DM– 2 years after surgery
• 51% EWL• 65% patients off all medications (insulin, oral)
• 30% EWL by 6 months after surgery--> more likely to be off all DM medications
![Page 13: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/13.jpg)
Resolution Rate of T2DMPonce, et al. Obes Surg (2004):14,1335-42
P<0.001 for >5 years vs <5 years at 12 and 18 months.
12 Months 18 Months
<5 Years’ Duration T2DM
Res
olu
tio
n R
ate
(%)
82.8%
33.3%
>5 Years’ Duration T2DM
90.9%
33.3%
n=35 n=18 n=22 n=12
All T2DM
n=53 n=34
66%70.5%
![Page 14: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/14.jpg)
HbA1c in T2DM PatientsPonce, et al. Obes Surg (2004):14,1335-42
Preop 12 Months 18 Months
Hb
A1c (
%)
7.257.00
7.7
5.875.64
6.355.68
5.40
6.25
All T2DM Patients<5 Years’ Duration T2DM>5 Years’ Duration T2DM
.
n=35 n=17 n=22 n=11n=35 n=18n=53 n=52 n=33
![Page 15: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/15.jpg)
%EWL in T2DM According to ResolutionPonce, et al. Obes Surg (2004):14,1335-42
Resolution
No Resolution
%E
WL 45.0%
27.0%
53.9%
27.5%
59.1%
26.5%
12 Months 18 Months 24 Months
n=35 n=17 n=24 n=9 n=12 n=3
P<0.001
P<0.001
P=0.005
![Page 16: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/16.jpg)
Rates of DM resolution after Bariatric Operations
Parikh et al, NYU JACS 2007;205:631-5
LAGB (n=218); RYGB (n=53); BPD/DS (n=11)LAGB (n=218); RYGB (n=53); BPD/DS (n=11)
![Page 17: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/17.jpg)
Swedish Band for the treatment of T2DM in Morbidly Obese
Brancatisano et al. SOARD 4(2008):423-9
![Page 18: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/18.jpg)
Swedish Band for the treatment of T2DM in Morbidly Obese
Brancatisano et al. SOARD 4(2008):423-9
![Page 19: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/19.jpg)
Change in Change in Glycosylated Hemoglobin (HbA1c)Glycosylated Hemoglobin (HbA1c)SAGB (2003-2006) US StudySAGB (2003-2006) US Study
Subjects with Hx of Diabetes
HbA1c (%) N Time
period Mean SD Range Change
Elevated 31 BL
36 mo 7.99 6.72
1.39 1.02
6.3 - 11.8 5.3 - 9.5
1.27*
Normal 14 BL
36 mo 5.51 5.73
0.34 0.26
5.0 - 6.1 5.4 - 6.2
0.21
Subjects without Hx of Diabetes
Elevated 17 BL
36 mo 6.75 5.81
0.69 0.24
6.2 – 8.4 5.3 - 6.1
0.94*
Normal 162 BL
36 mo 5.39 5.46
0.33 0.38
4.7 – 6.1 4.5 - 6.7
-0.07
Normal range for HbA1C 4.3-6.1%
* P <0.001 by t-test analysis
![Page 20: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/20.jpg)
THE MANAGEMENT OF OBESITYTHE MANAGEMENT OF OBESITY
A PROSPECTIVE RANDOMISED CONTROLLED TRIAL OF A PROSPECTIVE RANDOMISED CONTROLLED TRIAL OF MEDICAL VERSUS SURGICAL THERAPYMEDICAL VERSUS SURGICAL THERAPY
Paul O’BrienPaul O’Brien, , John Dixon, Cheryl Laurie, Stewart Skinner, Joe Proietto, John McNeil, Boyd Strauss, Sharon Marks, Linda
Schachter, Leon Chapman and Margaret Anderson.. Centre for Obesity Research and Education Centre for Obesity Research and Education
Monash University, Melbourne, AustraliaMonash University, Melbourne, Australia
Annals of Internal Medicine, May, 2006Annals of Internal Medicine, May, 2006
![Page 21: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/21.jpg)
RCT of Medical vs Surgical Therapy for Obesity % of Excess Weight Lost
8787%
21%21%
O’Brien et al, Ann Int Med. 2006O’Brien et al, Ann Int Med. 2006
![Page 22: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/22.jpg)
RCT of Medical vs Surgical Therapy for ObesityEffect on Metabolic SyndromeEffect on Metabolic Syndrome
N.S.
P < 0.001P < 0.001
%%
38%
24%
38%
3%
Surgical Change vs Medical Change P < 0.006
O’Brien et al, Ann Int Med. 2006O’Brien et al, Ann Int Med. 2006
![Page 23: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/23.jpg)
The Management of Type-2 DiabetesThe Management of Type-2 Diabetes
A Randomized Controlled Trial of A Randomized Controlled Trial of Surgical and Non-surgical TherapySurgical and Non-surgical Therapy
John B. Dixon, Paul E. O'Brien, Julie Playfair, Stewart John B. Dixon, Paul E. O'Brien, Julie Playfair, Stewart Skinner, Joseph Proietto, Linda M Schachter, Leon Skinner, Joseph Proietto, Linda M Schachter, Leon
Chapman, Margaret AndersonChapman, Margaret Anderson
Centre for Obesity Research and EducationCentre for Obesity Research and Education
Monash University, MelbourneMonash University, Melbourne
JAMAJAMA, Feb, 2008, Feb, 2008
![Page 24: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/24.jpg)
Type-2 Diabetes – A Randomised TrialType-2 Diabetes – A Randomised TrialWeight Loss - % of excess weight lostWeight Loss - % of excess weight lost
6565%
6%6%
![Page 25: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/25.jpg)
Type 2 Diabetes – A Randomised TrialType 2 Diabetes – A Randomised Trial
Weight Loss – Change in BMIWeight Loss – Change in BMI
36.336.3
28.428.4
37.137.1
![Page 26: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/26.jpg)
Type 2 Diabetes – A Randomised TrialType 2 Diabetes – A Randomised TrialRemission of Diabetes - ITTRemission of Diabetes - ITT
73%73%
13%13%
![Page 27: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/27.jpg)
Type-2 Diabetes – A Randomised TrialType-2 Diabetes – A Randomised Trial Effect on Metabolic Syndrome (ATP III criteria)Effect on Metabolic Syndrome (ATP III criteria)
(N.S.)
P < 0.001P < 0.001%%
97%
88%
97%
28%
Non-surgical vs Surgical Change P < 0.001
![Page 28: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/28.jpg)
Buchwald diabetes meta-analysisThe American Journal of Medicine (2009) 122, 248-256
![Page 29: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/29.jpg)
What is the mechanism of action?
• In RNY: – Schauer, et al (Ann Surg, 2003): 83% resolution,
only 30% had “immediate resolution” probably associated “hormonal effects”…concluded that resolution of diabetes was primarily “weight-loss driven”
– Weight regain may affect negatively diabetes remission
![Page 30: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/30.jpg)
What is the mechanism of action?
• LAGB: – Reduced caloric intake– Weight loss
![Page 31: Jaime Ponce MD, FACS, FASMBS Director of Bariatric Surgery Hamilton Medical Center Dalton Georgia USA LAGB Weight Loss and Diabetes 2010 Minimally Invasive](https://reader035.vdocuments.site/reader035/viewer/2022062717/56649e5d5503460f94b563df/html5/thumbnails/31.jpg)
Thank YouThank YouHamilton Ambulatory Surgery CenterHamilton Ambulatory Surgery Center
Dalton, GADalton, GA